Clinical Trial: Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title: AAD-PEPR: Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments

Brief Summary: This is designated to validate patient-reported outcomes (PRO) measures in itch-specific pediatric skin conditions, such as atopic dermatitis, and examine the ability of a modified stigma instrument to assess the severity and type of stigma experienced in atopic dermatitis and other potentially stigmatizing conditions.

Detailed Summary: This study involves a series of research and development projects targeted at two of the most common chronic diseases affecting children: asthma and atopic dermatitis (AD, or eczema). The Investigators propose to directly validate patient-reported outcomes (PRO) measures in a large cohort of itch-specific pediatric skin conditions, with a primary focus on AD. The Investigators propose to examine the ability of PROMIS (Patient-Reported Outcomes Measurement Information Systems) instruments to detect meaningful and clinically significant change in disease status, as well as to create a pediatric itch item pool and PRO model for signs and symptoms of skin disease. The Investigators will also examine the ability of a modified Neuro-QOL stigma instrument to assess the severity and type of stigma experienced in AD and across various dermatologic or other potentially stigmatizing conditions. Lurie Children's Hospital will only be involved in the AD and stigma portions of this project
Sponsor: Northwestern University

Current Primary Outcome: Analysis and Coding of Cognitive Interview Response [ Time Frame: 6 months duration of the study ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Northwestern University

Dates:
Date Received: February 9, 2017
Date Started: September 2016
Date Completion: September 2019
Last Updated: February 9, 2017
Last Verified: February 2017